FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Akorn Clindamycin Phosphate Topical Solution Recall

Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 pledget appli…

Akorn, Inc. · Decatur, IL

Risk level
Class III
Reported by FDA
Dec 5, 2018
Recall ID
D-1208-2019
Check your lot numberHow we source this data

Summary

Akorn recalled Clindamycin Phosphate Topical Solution starting Oct 29, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1208-2019 on Dec 5, 2018. Reason: Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities

Product description

Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 pledget applicators per jar, Rx only. Manufactured by Ei LLC 2865 N. Cannon Blvd. Kannapolis, NC 18083. NDC# 61748-0201-60

Lot numbers, UPCs & expiration codes

Lot# 2530200, Expiration date: 1/31/2019. Lot# 2530300, Expiration date: 1/31/2019. Lot# 2530400, Expiration date: 1/31/2019. Lot# 2607300, Expiration date: 1/31/2019. Lot# 2607400, Expiration date: 1/31/2019. Lot# 2607500, Expiration date: 1/31/2019. Lot# 2607600, Expiration date: 1/31/2019. Lot# 2615800, Expiration date: 1/31/2019. Lot# 2630200, Expiration date: 2/28/2019. Lot# 2630300, Expiration date: 2/28/2019.

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1208-2019
Classification
Class III
Status
Terminated
Recall initiated
Oct 29, 2018
FDA report date
Dec 5, 2018
Quantity
58,393 jars
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-1208-2019, exactly as published.

Show all FDA fields
City
Decatur
State
IL
Status
Terminated
Country
United States
Event ID
81426
Address
1222 W Grand Ave
Code information
Lot# 2530200, Expiration date: 1/31/2019. Lot# 2530300, Expiration date: 1/31/2019. Lot# 2530400, Expiration date: 1/31/2019. Lot# 2607300, Expiration date: 1/31/2019. Lot# 2607400, Expiration date: 1/31/2019. Lot# 2607500, Expiration date: 1/31/2019. Lot# 2607600, Expiration date: 1/31/2019. Lot# 2615800, Expiration date: 1/31/2019. Lot# 2630200, Expiration date: 2/28/2019. Lot# 2630300, Expiration date: 2/28/2019.
Postal code
62522-1412
Report date
Dec 5, 2018
Product type
Drugs
Recall number
D-1208-2019
Classification
Class III
Recalling firm
Akorn, Inc.
Product quantity
58,393 jars
Termination date
Aug 9, 2022
Reason for recall
Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 pledget applicators per jar, Rx only. Manufactured by Ei LLC 2865 N. Cannon Blvd. Kannapolis, NC 18083. NDC# 61748-0201-60
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Oct 29, 2018
Initial firm notification
Letter
Center classification date
Apr 23, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1208-2019, published Dec 5, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls